Location: San Francisco, CA
CIK: 0001799883 · Show all filings
Period: Q1 2021 (← Previous) (Next →)
Filing Date: May 17, 2021
Total Value: $555M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | VOR BIOPHARMA INC | 6,692,429 | $288M | 51.9% | $43.10 | — | COM | 929033108 |
| — | AKOUOS INC | 4,135,784 | $57.36M | 10.3% | $22.50 | — | COM | 00973J101 |
| — | HOMOLOGY MEDICINES INC | 4,535,919 | $42.68M | 7.7% | $20.70 | — | COM | 438083107 |
| IDYA | IDEAYA BIOSCIENCES INC | 1,798,066 | $42.26M | 7.6% | $7.13 | +170.6% | COM | 45166A102 |
| CABA | CABALETTA BIO INC | 2,984,263 | $33.13M | 6.0% | $11.85 | +3.1% | COM | 12674W109 |
| ARVN | ARVINAS INC | 500,000 | $33.05M | 6.0% | $29.28 | +161.3% | COM | 04335A105 |
| — | SCPHARMACEUTICALS INC | 3,831,474 | $25.48M | 4.6% | $5.92 | — | COM | 810648105 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 1,362,286 | $20.82M | 3.7% | $19.04 | -18.6% | COM | 22663K107 |
| — | CIDARA THERAPEUTICS INC | 2,006,511 | $5.337M | 1.0% | $3.84 | — | COM | 171757107 |
| — | 5 01 ACQUISITION CORP | 365,126 | $3.648M | 0.7% | $10.17 | — | COM CL A | 33836P105 |
| — | APREA THERAPEUTICS INC | 619,157 | $3.158M | 0.6% | $45.89 | — | COM | 03836J102 |